| Q57464013 | A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States |
| Q33721818 | A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men. |
| Q44766188 | AIDS-defining opportunistic illnesses in the HAART era in New York City |
| Q34636933 | AIDS-related cancer and severity of immunosuppression in persons with AIDS. |
| Q34115343 | Assessing the performance of a computer-based policy model of HIV and AIDS |
| Q37286865 | Associations and Trends in Cause-Specific Rates of Death Among Persons Reported with HIV Infection, 23 U.S. Jurisdictions, Through 2011. |
| Q52725458 | Atrial arrhythmia prevalence and characteristics for human immunodeficiency virus-infected persons and matched uninfected controls. |
| Q36933327 | Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring |
| Q35187455 | CCR2 genotype and disease progression in a treated population of HIV type 1-infected women |
| Q44985971 | Causes of first hospitalization among 1121 HIV-infected children: comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods |
| Q47833061 | Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy |
| Q36456737 | Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks |
| Q36461601 | Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection |
| Q35080529 | Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens |
| Q37596720 | CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo |
| Q34643410 | Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States |
| Q28289603 | Current epidemiology of Pneumocystis pneumonia |
| Q42380887 | Cytomegalovirus and paediatric HIV infection |
| Q50764081 | Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. |
| Q40577108 | Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity |
| Q36628396 | Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy |
| Q37388428 | Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States |
| Q35693261 | Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? |
| Q33585427 | Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters |
| Q35053172 | Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). |
| Q39463962 | Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States |
| Q35530073 | Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999 |
| Q37519715 | HIV protease inhibitors: recent clinical trials and recommendations on use. |
| Q44933768 | HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). |
| Q93501240 | HIV: prevention of opportunistic infections |
| Q33850498 | HIV: primary and secondary prophylaxis for opportunistic infections |
| Q36503629 | Health Protective Behaviors among Young People Living with HIV/AIDS |
| Q24685909 | Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS |
| Q33321334 | Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions. |
| Q35920633 | Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. |
| Q36088274 | Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. |
| Q73288063 | Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics |
| Q37906931 | In-hospital mortality rates and HIV: a medical ward review, Lilongwe, Malawi |
| Q34062712 | Incidence and risk factors for AIDS-related mortality in HIV patients in China: a cross-sectional study |
| Q36240585 | Incident Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Men Who Have Sex With Men From Pre-HAART to HAART Periods: A Cohort Study. |
| Q54449136 | Influence of IL-1 gene polymorphism on the periodontal microbiota of HIV-infected Brazilian individuals. |
| Q45128964 | Liver transplantation in patients with HIV infection: a reality in 2004 |
| Q34302103 | Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience |
| Q33864530 | Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention. |
| Q34522835 | Miliary tuberculosis coinfection with human immunodeficiency virus. |
| Q35452217 | Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004) |
| Q82029714 | Neuroepidemiology of HIV/AIDS |
| Q37180845 | Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities |
| Q75291756 | Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy |
| Q45050994 | Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors |
| Q82029809 | Other opportunistic infections of the central nervous system in AIDS |
| Q33369974 | Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. |
| Q38403451 | Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer |
| Q46943291 | Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways |
| Q35965602 | Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil |
| Q58857249 | Prevalence and risk factors associated with perianal ulcer in advanced acquired immunodeficiency syndrome |
| Q48572228 | Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. |
| Q34613114 | Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections |
| Q52638828 | Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy. |
| Q53840337 | Sources of racial/ethnic differences in awareness of HIV vaccine trials. |
| Q37919761 | The advent of successful organ transplantation in the Irish HIV positive cohort |
| Q35108693 | The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era |
| Q46685919 | Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients |
| Q43983382 | Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006 |
| Q38415403 | Trends in nontuberculous mycobacterial disease in hospitalized subjects in Spain (1997-2010) according to HIV infection |
| Q35232696 | Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study |
| Q35605497 | Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand |
| Q33833865 | Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China |